Good response with durvalumab after chemoradiotherapy for epidermal growth factor receptor exon 20 insertion adenocarcinoma: A case report

Epidermal growth factor receptor (EGFR) exon 20 insertion is not associated with sensitivity to EGFR tyrosine kinase inhibitors and chemotherapy. Here, we report the case of a 41-year-old man who presented a right lower lobe nodule and mediastinal lymph node enlargement diagnosed as EGFR exon 20 ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuura, Shun, Morikawa, Keisuke, Ito, Yutaro, Kagoo, Namio, Kubota, Tsutomu, Ichijo, Koshiro, Mochizuki, Eisuke, Uehara, Masahiro, Harada, Masanori, Tsukui, Masaru, Koshimizu, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552097/
https://www.ncbi.nlm.nih.gov/pubmed/33083220
http://dx.doi.org/10.1016/j.rmcr.2020.101236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552097/
https://www.ncbi.nlm.nih.gov/pubmed/33083220
http://dx.doi.org/10.1016/j.rmcr.2020.101236

Ejemplares similares